Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Science

• Publication date

  1983-05-27

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1126/SCIENCE.6133351PMID 6133351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A liquid chromatographic assay for 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in human body fluids.

  2009cited by this paper
• Perceptual capacity, functions of the corpus striatum and schizophrenia

  2005cited by this paper
• Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay.

  1982cited by this paper
• Cerebral ventricular size in twins discordant for schizophrenia.

  1982cited by this paper
• d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia.

  1982cited by this paper
• Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons

  1982cited by this paper
• Computed tomography in schizophreniform disorder and other acute psychiatric disorders.

  1982cited by this paper
• Cerebral ventricular enlargement in subtypes of chronic schizophrenia.

  1982cited by this paper
• Ventricular enlargement in schizophrenia: definition and prevalence.

  1982cited by this paper
• Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia.

  1982cited by this paper
• Ex uno multi: subtyping the schizophrenic syndrome.

  1982cited by this paper
• Increased brain dopamine and dopamine receptors in schizophrenia.

  1982cited by this paper
• Schizophrenia: dopamine beta-hydroxylase activity and treatment response.

  1982cited by this paper
• Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man.

  1981cited by this paper
• Homovanilic acid in Huntington's disease and Sydenham's chorea.

  1981cited by this paper
• Increased whole blood serotonin concentrations in chronic schizophrenic patients.

  1981cited by this paper
• Familial aspects of CT scan abnormalities in chronic schizophrenic patients.

  1981cited by this paper
• Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment.

  1980cited by this paper
• CSF monoamine metabolites in depression and schizophrenia.

  1980cited by this paper
• Poor premorbid adjustment and CT scan abnormalities in chronic schizophrenia.

  1980cited by this paper
• Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics. Measurement by the standardized Luria-Nebraska Neuropsychological Battery.

  1980cited by this paper
• Mental symptoms in Huntington's disease and a possible primary aminergic neuron lesion.

  1980cited by this paper
• Cognitive Impairment Associated with Morphological Brain Abnormalities on Computed Tomography in Chronic Schizophrenic Patients

  1980cited by this paper
• The dopamine hypothesis of schizophrenia revisited.

  1979cited by this paper
• Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia.

  1979cited by this paper
• Sulcal prominence in young chronic schizophrenic patients: CT scan findings associated with impairment on neuropsychological tests.

  1979cited by this paper
• Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid.

  1979cited by this paper
• Structural abnormalities in the cerebral cortex of chronic schizophrenic patients.

  1979cited by this paper
• Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.

  1978cited by this paper
• Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains

  1978cited by this paper
• Difficulties in comparing catecholamine-related enzymes from the brains of schizophrenics and controls.

  1978cited by this paper
• The activities of brain dopamine-β-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls

  1978cited by this paper
• Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.

  1978cited by this paper
• Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process.

  1978cited by this paper
• The dementia of dementia praecox

  1978cited by this paper
• Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.

  1978cited by this paper
• Norepinephrine-dopamine interactions and behavior.

  1977cited by this paper
• Seasonality of schizophrenic births in the United States.

  1977cited by this paper
• Cerebral ventricular size and cognitive impairment in chronic schizophrenia.

  1976cited by this paper
• Dopamine beta-hydroxylase activity in brains of chronic schizophrenic patients.

  1975cited by this paper
• The offspring of schizophrenics. Fetal and neonatal deaths.

  1975cited by this paper
• Cerebrospinal fluid amine metabolites in acute schizophrenia.

  1975cited by this paper
• Season of birth in the general population and in patients with mental disorder in Norway.

  1974cited by this paper
• Season of Birth in the General Population and in Patients with Mental Disorder in Norway

  1974cited by this paper
• Central dopamine turnover in schizophrenic syndromes.

  1974cited by this paper
• Dopamine.-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

  1973cited by this paper
• Dopamine-beta-hydroxylase deficits in the brains of schizophrenic patients.

  1973cited by this paper
• Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

  1971cited by this paper
• A sensitive enzymatic assay for dopamine- -hydroxylase.

  1971cited by this paper
• Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

  1969cited by this paper
• MONTH OF BIRTH AND SCHIZOPHRENIA

  1968cited by this paper
• [Schizophrenia and senile cerebral involution. Anatomo-pathologic and statistical study of 75 cases].

  1967cited by this paper
• CASE HISTORY DATA AND PROGNOSIS IN SCHIZOPHRENIA

  1953cited by this paper

• Deep sequencing identifies novel regulatory variants in the distal promoter region of the dopamine-?-hydroxylase gene

  2016cites this paper
• Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view

  2014cites this paper
• Association between dopamine beta hydroxylase gene polymorphism and age at onset in male schizophrenia

  2012cites this paper
• Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.

  2006cites this paper
• Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

  2005cites this paper
• Homovanillic acid concentrations in brain, CSF and plasma as indicators of central dopamine function in primates

  2005cites this paper
• Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function.

  2005cites this paper
• Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

  2004cites this paper
• Proposal for a noradrenaline hypothesis of schizophrenia.

  2004cites this paper
• Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia.

  2003cites this paper
• CSF monoamine metabolites and MRI brain volumes in alcohol dependence.

  2003cites this paper
• Dopamine Beta‐Hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study

  2003influential citation
• Drugs, Brains and Behavior

  2001cites this paper
• Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia.

  2001cites this paper
• The first, second, third and fourth order Markov chain analysis on the amino-acid sequence of human dopamine β-hydroxylase

  2000cites this paper
• GABA and brain abnormalities in schizophrenia.

  1998cites this paper
• TaqI polymorphic sites at the human dopamine β‐hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia

  1998cites this paper
• Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease.

  1998cites this paper
• BASES BIOLÓGICAS DE LA ESQUIZOFRENIA: ASPECTOS NEUROQUÍMICOS Y NEUROANATÓMICOS

  1998cites this paper
• Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia.

  1998cites this paper
• CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia.

  1998cites this paper
• THE EFFECTS OF DIET ON BEHAVIOR: IMPLICATIONS FOR CRIMINOLOGY AND CORRECTIONS

  1998cites this paper
• Subsyndromes of chronic schizophrenia: a phenomenological study

  1997cites this paper
• Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia

  1997cites this paper
• Dopamine Turnover in Schizophrenia Before and after Haloperidol Withdrawal

  1996cites this paper
• Blink rate, neurocognitive impairments, and symptoms in schizophrenia.

  1996cites this paper
• Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals

  1996cites this paper
• Negative Symptoms of Schizophrenia: Methodological Issues, Biochemical Findings and Efficacy of Neuroleptic Treatment

  1996cites this paper
• A study of enzymes involved in catecholamine metabolism in parents of patients with schizophrenia.

  1996cites this paper
• A study of the relationship between the DBH activity in serum and a MspI polymorphic site in intron 9 of the human DBH gene in schizophrenia.

  1996cites this paper
• Assessment of the central dopaminergic index of plasma HVA in schizophrenia.

  1995cites this paper
• Neurotransmitter systems in schizophrenia.

  1995cites this paper
• Association of polymorphic VNTR region in the first intron of the human TH gene with disturbances of the catecholamine pathway in schizophrenia

  1995cites this paper
• Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset.

  1995cites this paper
• Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables

  1994cites this paper
• Biochemische Hypothesen zur Negativ-Symptomatik der Schizophrenie

  1994cites this paper
• Free radical mechanisms in schizophrenia and tardive dyskinesia.

  1994cites this paper
• Premorbid adjustment in schizophrenia: implications for psychosocial and ventricular pathology.

  1994cites this paper
• CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures.

  1994cites this paper
• Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment. A review.

  1994cites this paper
• Parkinsonism in neuroleptic-naive schizophrenic patients.

  1993cites this paper
• The boundaries of schizophrenia.

  1993cites this paper
• Sensitivity to subjective effects of cocaine in drug abusers: relationship to cerebral ventricle size.

  1993cites this paper
• Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia.

  1993cites this paper
• Serum homovanillic acid levels in schizophrenic patients and normal control subjects.

  1993cites this paper
• A meta-analysis of homovanillic acid concentrations in schizophrenia.

  1993cites this paper
• All-night electroencephalographic sleep and cranial computed tomography in depression

  1992cites this paper
• CSF chromogranin A-like immunoreactivity in schizophrenia: relationships with REM latency and slow wave sleep.

  1992cites this paper
• Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects.

  1992cites this paper
• The Dopamine Hypothesis and Neurophysiology Concepts in Schizophrenia

  1992cites this paper
• The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia.

  1992cites this paper
• Hypnotizability and CSF HVA levels among psychiatric patients.

  1992cites this paper
• Neuroanatomic/Neuropathologic Correlates in Schizophrenia

  1992cites this paper
• Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls.

  1991cites this paper
• Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.

  1991cites this paper
• The relationship of pineal calcification to cortical atrophy in schizophrenia.

  1991cites this paper
• The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.

  1991cites this paper
• A selective review of possible neurological etiologies of schizophrenia

  1991cites this paper
• Neuroradiological covariates of drug-induced parkinsonism and tardive dyskinesia in schizophrenia.

  1991cites this paper
• The Dopamine System and Mental Disorders: Clinical and Psychopharmacological Overview

  1991cites this paper
• The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis

  1991cites this paper
• Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures.

  1991cites this paper
• Neuroimaging studies of schizophrenia.

  1991cites this paper
• CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.

  1991cites this paper
• Dopamine in schizophrenia: a review and reconceptualization.

  1991cites this paper
• Explorations of Dopamine and Noradrenaline Activity and Negative Symptoms in Schizophrenia: Concepts and Controversies

  1991cites this paper
• Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia.

  1991cites this paper
• Neuropeptide Y-like immunoreactivity in schizophrenia

  1990cites this paper
• Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo.

  1990cites this paper
• Diagnostic Advances in Anatomical and Functional Brain Imaging in Schizophrenia

  1990cites this paper
• Sleep disturbance and computerized axial tomographic scan findings in former prisoners of war.

  1990cites this paper
• Is negative schizophrenia a variant of parkinsonism

  1990cites this paper
• Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.

  1990cites this paper
• Are Biochemical Markers for Treatment‐Resistant Schizophrenia State Dependent or Traits?

  1990cites this paper
• Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

  1990cites this paper
• The relationship of negative schizophrenia to parkinsonism.

  1990cites this paper
• Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.

  1990cites this paper
• The Copenhagen High-Risk Study Premorbid and Clinical Dimensions of Maternal Schizophrenia

  1990cites this paper
• Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.

  1990cites this paper
• Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

  1989cites this paper
• Possible increase of dopamine-beta-hydroxylase activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study.

  1989cites this paper
• Neuropsychological Function and Brain Imaging

  1989cites this paper
• Structural Brain Abnormalities in the Major Psychoses

  1989cites this paper
• Beyond the Dopamine Hypothesis

  1989cites this paper
• Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems.

  1988cites this paper
• Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.

  1988cites this paper
• The Roles of Glucocorticoid and Dopaminergic Systems in Delusional (Psychotic) Depression a

  1988cites this paper
• Neuroanatomical Studies of Major Affective Disorders

  1988cites this paper
• Bilateral brain dysfunction during motor activation in type II schizophrenia measured by EEG mapping.

  1988cites this paper
• Ventricular-brain ratio and life course of illness in patients with affective disorder.

  1988cites this paper
• Nutrition and Childhood Neuropsychological Disorders

  1988cites this paper
• Perspectives on a time-dependent model of neuroleptic action.

  1988cites this paper
• New insights into schizophrenia through atypical antipsychotic drugs.

  1988cites this paper
• Schizophrenia: Instability in Norepinephrine, Serotonin, and γ-Aminobutyric Acid Systems

  1988cites this paper
• Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

  1988cites this paper
• Brain imaging: applications in psychiatry.

  1988cites this paper
• Medical Neuropsychology

  1988cites this paper
• Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia.

  1988cites this paper
• Brain computerized tomography in subtypes of severe chronic schizophrenia

  1988cites this paper
• Plasma Homovanillic Acid as an Index of Central Dopaminergic Activity: Studies in Schizophrenic Patients

  1988cites this paper